Portective Action of Angiotensin Converting Enzyme Inhibitors on Cardiac Hypertrophy in the Aortic-Banded Rat.
スポンサーリンク
概要
- 論文の詳細を見る
Imidapril, enalapril and quinapril were subcutaneously administered to aortic-banded rats by osmotic minipumps to compare the suppressive actions of these angiotensin converting enzyme (ACE) inhibitors on pressure-induced cardiac hypertrophy. Among the three drugs tested, imidapril was most potent for the prevention of cardiac hypertrophy, although equipotent hypotensive doses were used. Imidapril reduced both serum and cardiac ACE activities, while enalapril reduced only the former. Quinapril also reduced both, however, it was less potent at reducing the former compared to imidapril. Moreover, only imidapril significantly decreased left ventricular end diastolic pressure, which tended to be increased by aortic-banding. The lipophilicity of ACE inhibitors could not explain the more potent suppressive action of imidapril on cardiac hypertrophy because the lipophilicity of imidaprilat, an active metabolite of imidapril, was as low as an active metabolite of enalapril; i.e., much lower than an active metabolite of quinapril. The efficay of ACE inhibitors on pressure-induced cardiac hypertrophy depends not only on an inhibitory effect on cardiac. ACE activity, but also on other actions such as their effect on left ventricular end diastolic pressure.
- International Heart Journal刊行会の論文
著者
-
MINAMI Koichi
Discovery Research Laboratory, Tanabe Seiyaku Co., Ltd.
-
Ohashi Rikiya
Discovery Research Laboratory Tanabe Seiyaku Co. Ltd.
-
Kurosawa Yukie
Discovery Research Laboratory Tanabe Seiyaku Co. Ltd.
-
Narita Hiroshi
Discovery Research Laboratories Tanabe Seiyaku Co. Ltd.
-
KOJIMA Koki
Discovery Research Laboratory, Tanabe Seiyaku Co., Ltd., Toda, Saitama, Japan
-
KUROSAWA Yukie
Discovery Research Laboratory, Tanabe Seiyaku Co., Ltd., Toda, Saitama, Japan
-
KATO Makoto
Discovery Research Laboratory, Tanabe Seiyaku Co., Ltd., Toda, Saitama, Japan
関連論文
- cGMP-Phosphodiesterase Activity Is Up-regulated in Response to Pressure Overload of Rat Ventricles(Biochemistry & Molecular Biology)
- Effects of Fluvastatin and Its Major Metabolites on Low-Density Lipoprotein Oxidation and Cholesterol Esterification in Macrophages
- Fluvastatin, an HMG-CoA Reductase Inhibitor, Protects LDL from Oxidative Modification in Hypercholesterolemic Rabbits
- In Vitro Inhibitory Effects of the Optical Isomers and Metabolites of Fluvastatin on Copper Ion-Induced LDL Oxidation
- Inhibitory Effects of Fluvastatin and Its Metabolites on Hydrogen Peroxide-Induced Oxidative Destruction of Hemin and Low-Density Lipoprotein
- Focal Cerebral Ischemia-Induced Escape Deficit in Rats Is Ameliorated by a Reversible Inhibitor of Monoamine Oxidase-A : Implications for a Novel Animal Model of Post-Stroke Depression
- Protective Effect of TA-993, a Novel Therapeutic Agent for Peripheral Circulatory Insufficiency, on Skeletal Muscle Fatigue in a Rat Model of Hindlimb Ischemia
- Food Deprivation Depletes Gastric Mucus Glycoprotein in Streptozotocin-Induced Diabetic Rats
- Usefulness and Limitation of DiBAC_4(3), a Voltage-Sensitive Fluorescent Dye, for the Measurement of Membrane Potentials Regulated by Recombinant Large Conductance Ca^-Activated K^+ Channels in HEK293 Cells
- Superoxide Anion Scavenging Properties of Fluvastatin and Its Metabolites
- A Novel Na^+ and Ca^ Channel Blocker, T-477, Prevents Brain Edema Following Microsphere-Induced Permanent Occlusion of Cerebral Arterioles in Rats
- Time-Dependent Changes in the Ischemic Forebrain Following the Microsphere-Induced Permanent Occlusion of Cerebral Arterioles in Rats
- Comparative Study of TA-606, a Novel Angiotensin II Receptor Antagonist, With Losartan in Terms of Species Difference and Orthostatic Hypotension
- Portective Action of Angiotensin Converting Enzyme Inhibitors on Cardiac Hypertrophy in the Aortic-Banded Rat.